Cargando…

Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients?

BACKGROUND: TB diagnostic and treatment services in India are provided free of cost in the programmatic context across the country. There are different costs incurred during health care utilization, and this study was conducted to estimate such costs. Methodology. A longitudinal study was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Poornima, M. P., Shruthi, M. N., Chingale, Ashwini Laxmanrao, Veena, V., Nagaraja, Sharath Burugina, Madhukeshwar, Akshaya Kibballi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238341/
https://www.ncbi.nlm.nih.gov/pubmed/32455013
http://dx.doi.org/10.1155/2020/3845694
_version_ 1783536521226223616
author Poornima, M. P.
Shruthi, M. N.
Chingale, Ashwini Laxmanrao
Veena, V.
Nagaraja, Sharath Burugina
Madhukeshwar, Akshaya Kibballi
author_facet Poornima, M. P.
Shruthi, M. N.
Chingale, Ashwini Laxmanrao
Veena, V.
Nagaraja, Sharath Burugina
Madhukeshwar, Akshaya Kibballi
author_sort Poornima, M. P.
collection PubMed
description BACKGROUND: TB diagnostic and treatment services in India are provided free of cost in the programmatic context across the country. There are different costs incurred during health care utilization, and this study was conducted to estimate such costs. Methodology. A longitudinal study was conducted among patients of three urban tuberculosis units (TUs) of Davangere, Belagavi, and Bengaluru, Karnataka. Trained data collectors administered a validated questionnaire and recorded monthly costs incurred by the patients which are expressed in median Indian National Rupees (INR). The analysis was done using SPSS version 23.0. A p value of <0.05 was taken as statistically significant. RESULTS: Among 214 patients, about 37%, 42%, and 21% belonged to Davangere, Belagavi, and Bengaluru, respectively. Median total pre- and postdiagnostic costs incurred across the three TUs were 3800 and 4000 INR, respectively. The direct nonmedical cost was higher for accommodation (median cost of 800 INR) and direct medical cost for non-TB drugs (median cost of 2000 INR). However, maximum direct medical and nonmedical costs were attributed to hospital admissions (1200 INR) and accommodation costs (700 INR) in the postdiagnostic period, respectively. The median indirect cost incurred was 300 INR overall, and the maximum total indirect cost was 40000 INR in the postdiagnostic period. About one-third of patients faced loss of income and 19.6% faced coping costs. Patients spent about 6.7% (0.97%–52.3%) of their income on TB treatment. About 12.3% patients faced catastrophic expenditure. Median cost was significantly higher among those seeking private health care facilities (12100 INR in private vs. 6800 INR in public; p < 0.05) during the prediagnostic period. Prediagnostic and diagnostic out-of-pocket expenditures (OPE) were significantly higher across all the three centres (p < 0.05). CONCLUSION: The TB patients experienced untoward expenditure under programmatic settings. The costs encountered by one in eight patients were catastrophic by nature.
format Online
Article
Text
id pubmed-7238341
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72383412020-05-22 Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients? Poornima, M. P. Shruthi, M. N. Chingale, Ashwini Laxmanrao Veena, V. Nagaraja, Sharath Burugina Madhukeshwar, Akshaya Kibballi Tuberc Res Treat Research Article BACKGROUND: TB diagnostic and treatment services in India are provided free of cost in the programmatic context across the country. There are different costs incurred during health care utilization, and this study was conducted to estimate such costs. Methodology. A longitudinal study was conducted among patients of three urban tuberculosis units (TUs) of Davangere, Belagavi, and Bengaluru, Karnataka. Trained data collectors administered a validated questionnaire and recorded monthly costs incurred by the patients which are expressed in median Indian National Rupees (INR). The analysis was done using SPSS version 23.0. A p value of <0.05 was taken as statistically significant. RESULTS: Among 214 patients, about 37%, 42%, and 21% belonged to Davangere, Belagavi, and Bengaluru, respectively. Median total pre- and postdiagnostic costs incurred across the three TUs were 3800 and 4000 INR, respectively. The direct nonmedical cost was higher for accommodation (median cost of 800 INR) and direct medical cost for non-TB drugs (median cost of 2000 INR). However, maximum direct medical and nonmedical costs were attributed to hospital admissions (1200 INR) and accommodation costs (700 INR) in the postdiagnostic period, respectively. The median indirect cost incurred was 300 INR overall, and the maximum total indirect cost was 40000 INR in the postdiagnostic period. About one-third of patients faced loss of income and 19.6% faced coping costs. Patients spent about 6.7% (0.97%–52.3%) of their income on TB treatment. About 12.3% patients faced catastrophic expenditure. Median cost was significantly higher among those seeking private health care facilities (12100 INR in private vs. 6800 INR in public; p < 0.05) during the prediagnostic period. Prediagnostic and diagnostic out-of-pocket expenditures (OPE) were significantly higher across all the three centres (p < 0.05). CONCLUSION: The TB patients experienced untoward expenditure under programmatic settings. The costs encountered by one in eight patients were catastrophic by nature. Hindawi 2020-05-11 /pmc/articles/PMC7238341/ /pubmed/32455013 http://dx.doi.org/10.1155/2020/3845694 Text en Copyright © 2020 M. P. Poornima et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Poornima, M. P.
Shruthi, M. N.
Chingale, Ashwini Laxmanrao
Veena, V.
Nagaraja, Sharath Burugina
Madhukeshwar, Akshaya Kibballi
Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients?
title Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients?
title_full Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients?
title_fullStr Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients?
title_full_unstemmed Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients?
title_short Cost of Tuberculosis Care in Programmatic Settings from Karnataka, India: Is It Catastrophic for the Patients?
title_sort cost of tuberculosis care in programmatic settings from karnataka, india: is it catastrophic for the patients?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238341/
https://www.ncbi.nlm.nih.gov/pubmed/32455013
http://dx.doi.org/10.1155/2020/3845694
work_keys_str_mv AT poornimamp costoftuberculosiscareinprogrammaticsettingsfromkarnatakaindiaisitcatastrophicforthepatients
AT shruthimn costoftuberculosiscareinprogrammaticsettingsfromkarnatakaindiaisitcatastrophicforthepatients
AT chingaleashwinilaxmanrao costoftuberculosiscareinprogrammaticsettingsfromkarnatakaindiaisitcatastrophicforthepatients
AT veenav costoftuberculosiscareinprogrammaticsettingsfromkarnatakaindiaisitcatastrophicforthepatients
AT nagarajasharathburugina costoftuberculosiscareinprogrammaticsettingsfromkarnatakaindiaisitcatastrophicforthepatients
AT madhukeshwarakshayakibballi costoftuberculosiscareinprogrammaticsettingsfromkarnatakaindiaisitcatastrophicforthepatients